Project Details
Description
Long-term Follow-Up of Participants of the Phase II study to evaluate subcutaneous abatacept vs placebo in diffuse cutaneous systemic sclerosis - a double-blind, placebo-controlled, randomized trial
| Status | Active |
|---|---|
| Effective start/end date | 1/1/19 → 12/31/24 |
Funding
- University of Michigan
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.